Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGPhase 3INTERVENTIONAL

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL STUDY EVALUATING THE SAFETY, TOLERABILITY, IMMUNOGENICITY AND EFFICACY OF A VARIANT-ADAPTED BNT162B2 VACCINE IN HEALTHY PARTICIPANTS 50 THROUGH 64 YEARS OF AGE

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine that doesn't contain an ingredient to protect against COVID-19 (placebo).

Who May Be Eligible (Plain English)

Key Inclusion Criteria - People who are between 50 and 64 years old at their first appointment. - People who are healthy and, based on their medical history and a doctor's judgment, are considered suitable to join the study. Key Exclusion Criteria - People who had COVID-19 in the past 3 months (90 days) before their first visit. - People who got a COVID-19 vaccine, either as part of a research study or an approved vaccine, in the last 3 months-or plans to get one during the study. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Key Inclusion Criteria * People who are between 50 and 64 years old at their first appointment. * People who are healthy and, based on their medical history and a doctor's judgment, are considered suitable to join the study. Key Exclusion Criteria * People who had COVID-19 in the past 3 months (90 days) before their first visit. * People who got a COVID-19 vaccine, either as part of a research study or an approved vaccine, in the last 3 months-or plans to get one during the study.

Treatments Being Tested

BIOLOGICAL

BNT162b2 Vaccine

Single dose

BIOLOGICAL

Placebo

Single dose

Locations (20)

Pinnacle Research Group, LLC
Anniston, Alabama, United States
North Alabama Research Center
Athens, Alabama, United States
Simon Williamson Clinic / Synexus Clinical Research US, Inc.
Birmingham, Alabama, United States
Accel Research Sites - Birmingham Clinical Research Unit
Birmingham, Alabama, United States
Cullman Clinical Trials
Cullman, Alabama, United States
AMR Clinical
Daphne, Alabama, United States
Medical Affiliated Research Center
Huntsville, Alabama, United States
AMR Clinical
Mobile, Alabama, United States
Chandler Clinical Trials
Chandler, Arizona, United States
Synexus Clinical Research US, Inc.
Phoenix, Arizona, United States
Scottsdale Clinical Trials
Scottsdale, Arizona, United States
Epic Medical Research-Sun City
Sun City, Arizona, United States
Noble Clinical Research
Tucson, Arizona, United States
Synexus Clinical Research US, Inc./Orange Grove Family Practice
Tucson, Arizona, United States
Woodland International Research Group
Little Rock, Arkansas, United States
Anaheim Clinical Trials, LLC
Anaheim, California, United States
Velocity Clinical Research, Chula Vista
Chula Vista, California, United States
West Coast Research
Dublin, California, United States
Leading Edge Research LA
Encino, California, United States
Leading Edge Research
Encino, California, United States